Imiquimod como tratamiento de la micosis fungoide palpebral
- J. Soler-Machín
- Y. Gilaberte-Calzada
- J. Vera-Álvarez
- C. Coscojuela-Santaliestra
- J. Martínez-Morales
- M. Osán-Tello
ISSN: 0365-6691
Year of publication: 2006
Volume: 81
Issue: 4
Pages: 221-224
Type: Article
More publications in: Archivos de la Sociedad Española de Oftalmologia
Abstract
Clinical case: Our patient was a 37-year-old male with palpebral mycosis fungoides, the most common T-cell cutaneous lymphoma. He had been treated previously with topical corticosteroids. We treated him with Imiquimod cream (5%) three times a week. Discussion: A clinical improvement was obtained with this drug, so we believe immuno-modulating agents need to be considered in the treatment of palpebral mycosis fungoides, especially because of its capacity of being a reflection of leukaemia.
Bibliographic References
- Montserrat Costa, E, Díaz-Mediavilla, J, Moraleda Jiménez, JM, Campo Guerri, E, Bosch Albareda, F, López-Guillermo, A. (2004). Compendio de Medicina Interna. Elsevier España. Madrid.
- Durand, L, Magnard, G, Trepsat, C. (1971). Palpebral localization of mycosis fungoides: Therapeutic attitude. Bull Soc Ophtalmol Fr. 71. 723-724
- Wong, SS, Goh, CL. (1999). Milia en plaque. Clin Exp Dermatol. 24. 183-185
- Gallardo, F, Pujol, RM. (2004). Diagnóstico y tratamiento de los linfomas cutáneos de células T primarios. Actas Dermosifiliogr. 95. 473-490
- Suchin, KR, Junkins-Hopkins, JM, Rook, AH. (2002). Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod. Arch Dermatol. 138. 1137-1139